Online citations, reference lists, and bibliographies.
← Back to Search

Lipid-based Nanovesicles For Nanomedicine.

N. Grimaldi, Fabiane Andrade, N. Segovia, L. Ferrer-Tasies, S. Sala, J. Veciana, N. Ventosa
Published 2016 · Computer Science, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Molecular self-assembly has enabled the fabrication of biologically inspired, advanced nanostructures as lipid-based nanovesicles (L-NVs). The oldest L-NVs, liposomes, have been widely proposed as potential candidates for drug delivery, diagnostic and/or theranostic applications and some liposome-based drug products have already stepped from the lab-bench to the market. This success is attributed to their ability to encapsulate both hydrophobic and/or hydrophilic molecules, efficiently carry and protect them within the body and finally deliver them at the target site. These positive features are also coupled with high biocompatibility. However, liposomes still present some unsolved drawbacks, such as poor colloidal stability, short shelf-life, restricted and expensive conditions of preparation because of the inherent nature of their fundamental constituents (phospholipids). The new tools available in the self-assembly of controlled molecules have significantly advanced the field of L-NV design and synthesis, and non-liposomal L-NVs have been recently developed; this new generation of nanovesicles can represent a paradigm shift in nanomedicine: they may complement liposomes, showing their advantages and overcoming most of their drawbacks. Clearly, being still young, their rocky way to the clinic first and then to the market has just started and it is still long, but they have all the potentialities to reach their objective target. The purpose of this review is to first present the large plethora of L-NVs available, focusing on this new generation of non-liposomal L-NVs and showing their similarities and differences with respect to their ancestors (liposomes). Since the overspread of a nanomaterial to the market is also strongly dependent on the availability of technological-scale preparation methods, we will also extensively review the current approaches exploited for L-NV production. The most cutting-edge approaches based on compressed fluid (CF) technologies will be highlighted here since they show the potential to represent a game-change in the production of L-NVs, favouring their step from the bench to the market. Finally, we will briefly discuss L-NV applications in nanomedicine, looking also for their future perspectives.
This paper references
Drulis - Kawa and A . Dorotkiewicz - Jach
L. Cattel (1995)
10.1093/JAC/DKG317
Liposomal tobramycin against pulmonary infections of Pseudomonas aeruginosa: a pharmacokinetic and efficacy study following single and multiple intratracheal administrations in rats.
J. Marier (2003)
10.1016/J.APSB.2011.09.002
Nonionic surfactant vesicular systems for effective drug delivery—an overview
G. P. Kumar (2011)
10.1016/S0378-5173(01)00627-5
Effect of liposomes and niosomes on skin permeation of enoxacin.
J. Fang (2001)
10.3109/10837450.2015.1078353
Anti-inflammatory effects of eugenol nanoemulsion as a topical delivery system
F. Esmaeili (2016)
10.2147/IJN.S84295
Virosomes of hepatitis B virus envelope L proteins containing doxorubicin: synergistic enhancement of human liver-specific antitumor growth activity by radiotherapy
Q. Liu (2015)
10.1016/j.biomaterials.2012.05.026
Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel.
S. Jain (2012)
10.1016/J.JCONREL.2007.08.005
Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
V. Dubey (2007)
10.1007/s12272-012-0112-0
Ethosomes, binary ethosomes and transfersomes of terbinafine hydrochloride: A comparative study
J. Zhang (2012)
10.2147/IJN.S26766
Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy
Hsin-I Chang (2012)
10.1021/JA0318030
Controlled vesicle self-assembly in microfluidic channels with hydrodynamic focusing.
A. Jahn (2004)
10.1046/J.1432-1327.2000.01447.X
Liposome-mediated cytosolic delivery of macromolecules and its possible use in vaccine development.
M. Owais (2000)
10.2147/IJN.S57314
Evaluation of psoralen ethosomes for topical delivery in rats by using in vivo microdialysis
Yongtai Zhang (2014)
10.1016/J.REACTFUNCTPOLYM.2010.10.002
Oral protein delivery: Current status and future prospect
K. Park (2011)
10.1016/J.BBAMEM.2006.01.023
Preparation of submicron unilamellar liposomes by freeze-drying double emulsions.
T. Wang (2006)
10.3797/scipharm.1208-02
Transfersomes: A Novel Vesicular Carrier for Enhanced Transdermal Delivery of Sertraline: Development, Characterization, and Performance Evaluation
Ankit Gupta (2012)
10.3109/10717544.2014.902146
Novel carbopol-based transfersomal gel of 5-fluorouracil for skin cancer treatment: in vitro characterization and in vivo study
Mohammed Ashif Khan (2015)
10.2147/IJN.S29827
A novel lipid-based nanomicelle of docetaxel: evaluation of antitumor activity and biodistribution
Mingshu Ma (2012)
10.1016/j.jconrel.2014.04.015
Nano-niosomes as nanoscale drug delivery systems: an illustrated review.
Saeid Moghassemi (2014)
10.1016/S0005-2736(97)00177-6
Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin.
G. Cevc (1998)
10.1186/s12944-016-0235-2
Targeting doxorubicin encapsulated in stealth liposomes to solid tumors by non thermal diode laser
M. M. Ghannam (2016)
10.1158/1538-7445.AM2014-CT327
Abstract CT327: Multicenter phase I study of MRX34, a first-in-class microRNA miR-34 mimic liposomal injection
M. Beg (2014)
10.1515/ejnm-2013-0005
Therapeutic delivery using cell-penetrating peptides
R. Sawant (2013)
10.1073/PNAS.76.1.145
Formation and properties of 1000-A-diameter, single-bilayer phospholipid vesicles.
H. Enoch (1979)
10.1016/j.addr.2011.06.013
Polymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapy.
S. Prakash (2011)
10.1038/sj.bjc.6603267
Multicentre phase II pharmacokinetic and pharmacodynamic study of OSI-7904L in previously untreated patients with advanced gastric or gastroesophageal junction adenocarcinoma
S. Falk (2006)
10.1038/275754A0
Enzyme replacement using liposome carriers in feline GM1 gangliosidosis fibroblasts
G. Reynolds (1978)
10.1016/0005-2736(85)90156-7
Extemporaneous preparation of large unilamellar liposomes.
J. Philippot (1985)
10.1016/J.IJPHARM.2006.08.002
In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin.
A. Pardakhty (2007)
10.1007/S11051-007-9340-5
Preparation of nanoparticles by continuous-flow microfluidics
A. Jahn (2008)
10.1615/CRITREVTHERDRUGCARRIERSYST.2013005964
Drug carrier systems for solubility enhancement of BCS class II drugs: a critical review.
S. Kumar (2013)
10.1016/j.nano.2011.11.008
In vitro mechanistic study of cell death and in vivo performance evaluation of RGD grafted PEGylated docetaxel liposomes in breast cancer.
S. Naik (2012)
10.1021/CG200356X
Crystallization of Microparticulate Pure Polymorphs of Active Pharmaceutical Ingredients Using CO 2 -Expanded Solvents
S. Sala (2012)
Meure, The Development of a Novel Process for the 24 |
J. Veciana (2012)
10.2174/1874126600701010036
Innovative Strategies for Enhancing Topical and Transdermal Drug Delivery
Desmond I. J. Morrow (2007)
10.1002/ADMA.200700941
Biomimetic pH Sensitive Polymersomes for Efficient DNA Encapsulation and Delivery
Hannah Lomas (2007)
10.1016/j.ijpharm.2009.11.033
Liposomes as delivery systems for antibiotics.
Z. Drulis-Kawa (2010)
10.1016/j.ijpharm.2007.11.035
Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains.
M. Alipour (2008)
10.1111/j.1742-7843.2011.00851.x
Airway Effects of Inhaled Quaternary Ammonium Compounds in Mice
S. T. Larsen (2012)
10.1021/nl9009793
Gold, poly(beta-amino ester) nanoparticles for small interfering RNA delivery.
J. Lee (2009)
10.2217/nnm.13.131
Liposomal drug products and recent advances in the synthesis of supercritical fluid-mediated liposomes.
P. R. Karn (2013)
10.1517/17425247.2012.735658
Liposomal delivery of proteins and peptides
Janani Swaminathan (2012)
10.1021/JA012091L
The formation of polymer vesicles or "peptosomes" by polybutadiene-block-poly(L-glutamate)s in dilute aqueous solution.
Hildegard Kukula (2002)
10.1038/nrd4333
Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery
V. Torchilin (2014)
10.1016/J.IJPHARM.2005.09.010
Spray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosol drug delivery.
L. Sweeney (2005)
10.1007/S00396-006-1554-Z
Characterization of polymeric vesicles of poly(sodium 11-acrylamidoundecanoate) in water
R. R. Nayak (2006)
10.1002/cncr.24359
Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non‐Hodgkin lymphoma
M. Rodriguez (2009)
10.1111/j.1749-6632.1978.tb22027.x
PREPARATION AND PROPERTIES OF ETHER‐INJECTION LIPOSOMES *
D. Deamer (1978)
10.1126/SCIENCE.291.5510.1944
Spherical bilayer vesicles of fullerene-based surfactants in water: a laser light scattering study.
S. Zhou (2001)
10.3892/IJO.17.2.309
Targeted delivery of anticancer drugs with intravenously administered magnetic liposomes in osteosarcoma-bearing hamsters.
T. Kubo (2000)
10.1016/j.jconrel.2010.06.022
Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblasts.
C. Marianecci (2010)
10.1097/00006454-200404000-00005
Comparison of immunogenicity and tolerability of a virosome-adjuvanted and a split influenza vaccine in children
G. Kanra (2004)
10.1016/j.jsps.2010.07.003
Effect of formulation design and freeze-drying on properties of fluconazole multilamellar liposomes.
Ola H El-Nesr (2010)
10.1166/JNN.2014.9080
Liposomes: versatile and biocompatible nanovesicles for efficient biomolecules delivery.
S. Mallick (2014)
10.1016/0304-4165(78)90240-4
Comparison of large unilamellar vesicles prepared by a petroleum ether vaporization method with multilamellar vesicles: ESR, diffusion and entrapment analyses.
H. Schieren (1978)
10.1016/J.SUPFLU.2010.02.005
Preparation of PEGylated liposomes of docetaxel using supercritical fluid technology
S. Naik (2010)
10.1016/J.IJPHARM.2006.12.005
Lipid vesicles for skin delivery of drugs: reviewing three decades of research.
M. M. Elsayed (2007)
10.1016/0005-2736(73)90314-3
Phase transitions in phospholipid vesicles. Fluorescence polarization and permeability measurements concerning the effect of temperature and cholesterol.
D. Papahadjopoulos (1973)
10.1073/PNAS.75.9.4194
Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation.
F. Szoka (1978)
10.18632/oncotarget.8360
Multifunctional targeting vinorelbine plus tetrandrine liposomes for treating brain glioma along with eliminating glioma stem cells
X. Li (2016)
10.1111/j.1749-6632.2000.tb07063.x
Feasibility, Phase I, and Pharmacological Study of Aerosolized Liposomal 9‐Nitro‐20(S)‐Camptothecin in Patients with Advanced Malignancies in the Lungs
C. Verschraegen (2000)
10.1208/s12249-008-9121-1
Effect of Charged and Non-ionic Membrane Additives on Physicochemical Properties and Stability of Niosomes
V. Junyaprasert (2008)
10.1016/j.ijpharm.2014.06.001
Comparison of ethosomes and liposomes for skin delivery of psoralen for psoriasis therapy.
Yongtai Zhang (2014)
10.1016/j.addr.2013.08.004
Nanopreparations to overcome multidrug resistance in cancer.
N. Patel (2013)
10.1016/J.JCIS.2004.02.048
Multilayer vesicles and vesicle clusters formed by the fullerene-based surfactant C60(CH3)5K.
C. Burger (2004)
10.2478/v10007-009-0023-x
Development and physicochemical evaluation of pharmacosomes of diclofenac
A. Semalty (2009)
10.1021/NL061412U
Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems.
N. Nasongkla (2006)
10.1016/0005-2736(95)00005-N
Recognition and clearance of liposomes containing phosphatidylserine are mediated by serum opsonin.
D. Liu (1995)
10.1021/la302620t
Influence of cholesterol on the phase transition of lipid bilayers: a temperature-controlled force spectroscopy study.
Lorena Redondo-Morata (2012)
10.1016/J.CHERD.2010.01.020
Preparation of liposomes entrapping essential oil from Atractylodes macrocephala Koidz by modified RESS technique
Zhen Wen (2010)
10.1016/j.jconrel.2013.03.036
Thermosensitive liposomes for localized delivery and triggered release of chemotherapy.
Terence Ta (2013)
Antibacterial activity of liposome-entrapped streptomycin in mice infected with mycobacterium tuberculosis.
Vladimirsky Ma (1982)
10.1016/j.ejpb.2012.02.009
Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose.
M. Niu (2012)
10.1208/s12249-014-0155-2
Aerosol Performance and Long-Term Stability of Surfactant-Associated Liposomal Ciprofloxacin Formulations with Modified Encapsulation and Release Properties
D. Cipolla (2014)
10.1080/08982100902788390
A novel procedure for preparation of submicron liposomes-lyophilization of oil-in-water emulsions
Ting Wang (2009)
10.1016/b978-0-08-044553-3.x5000-0
Nanotechnology for Microelectronics and Optoelectronics
J. M. Martínez-Duart (2006)
10.3109/10837450.2015.1048553
Ufasomes nano-vesicles-based lyophilized platforms for intranasal delivery of cinnarizine: preparation, optimization, ex-vivo histopathological safety assessment and mucosal confocal imaging
A. Salama (2016)
10.1002/JCP.1040730108
Formation and properties of thin‐walled phospholipid vesicles
J. Reeves (1969)
10.1016/j.ijpharm.2016.01.017
Transdermal glimepiride delivery system based on optimized ethosomal nano-vesicles: Preparation, characterization, in vitro, ex vivo and clinical evaluation.
T. Ahmed (2016)
10.1021/la802511a
The depressurization of an expanded solution into aqueous media for the bulk production of liposomes.
Louise A. Meure (2009)
10.1039/F29767201525
Theory of self-assembly of hydrocarbon amphiphiles into micelles and bilayers
J. Israelachvili (1976)
10.1016/j.biomaterials.2008.09.056
Single-step surface functionalization of polymeric nanoparticles for targeted drug delivery.
Y. Patil (2009)
10.1021/LA050211N
Enhanced drug transport from unilamellar to multilamellar liposomes induced by molecular recognition of their lipid membranes.
A. Pantos (2005)
10.1016/S0378-5173(01)00721-9
Filter extrusion of liposomes using different devices: comparison of liposome size, encapsulation efficiency, and process characteristics.
N. Berger (2001)
10.1016/S0896-8446(00)00076-0
Soy lecithin micronization by precipitation with a compressed fluid antisolvent — influence of process parameters
C. Magnan (2000)
10.3109/10717544.2012.724472
Comparative study of liposomes, transfersomes and ethosomes as carriers for improving topical delivery of celecoxib
M. Bragagni (2012)
10.1039/C0SM01307B
Stimulus responsive nanogels for drug delivery
Liusheng Zha (2011)
10.1126/SCIENCE.284.5417.1143
Polymersomes: tough vesicles made from diblock copolymers.
B. Discher (1999)
10.1155/2011/863734
Recent Applications of Liposomes in Ophthalmic Drug Delivery
G. P. Mishra (2011)
10.1016/J.NANO.2007.08.003
In vitro studies on liposomal amphotericin B obtained by supercritical carbon dioxide-mediated process.
Udaya Sankar Kadimi (2007)
10.1021/la502594k
Formation of nanocarrier systems by dense gas processing.
C. C. Beh (2014)
10.4103/0975-8453.86290
Ufasomes: A vesicular drug delivery
Dasharath M. Patel (2011)
10.1126/SCIENCE.1095833
Drug Delivery Systems: Entering the Mainstream
T. Allen (2004)
10.1021/LA051206M
Spontaneously formed vesicles of sodium N-(11-acrylamidoundecanoyl)-glycinate and L-alaninate in water.
Sumita Roy (2005)
10.1021/LA951057F
Didodecyldimethylammonium Bromide Vesicles and Lamellar Liquid Crystals. A Multinuclear NMR and Optical Microscopy Study
Francesca Caboi and (1996)
Clinical Trial of BP1001 (L-Grb-2 Antisense Oligonucleotide) in CML, AML, ALL & MDS. NCT01159028
Bio-Path Holdings (2013)
10.2337/DIACARE.28.7.1630
Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial.
J. Skyler (2005)
10.1016/j.vaccine.2009.06.019
Respiratory syncytial virus subunit vaccine based on a recombinant fusion protein expressed transiently in mammalian cells.
Sophie Nallet (2009)
10.1021/LA00055A011
Phase behavior and scattering of double-chain surfactants in diluted aqueous solutions
M. Dubois (1991)
10.1088/0957-4484/25/27/275103
Two cholesterol derivative-based PEGylated liposomes as drug delivery system, study on pharmacokinetics and drug delivery to retina.
Sheng-Yong Geng (2014)
10.1002/adma.201600797
Smart Gating Multi-Scale Pore/Channel-Based Membranes.
Xu Hou (2016)
10.1042/BJ1290123
Lysosomal localization of -fructofuranosidase-containing liposomes injected into rats.
G. Gregoriadis (1972)
10.1021/nn5011914
Virus-Inspired Membrane Encapsulation of DNA Nanostructures To Achieve In Vivo Stability
Steven D. Perrault (2014)
10.1164/AJRCCM/144.3_PT_1.575
Therapeutic efficacy of liposome-encapsulated kanamycin against Mycobacterium intracellulare infection induced in mice.
H. Tomioka (1991)
10.1002/JPS.20332
Optimization and characterization of a sphingomyelin/cholesterol liposome formulation of vinorelbine with promising antitumor activity.
S. Semple (2005)
10.1016/S0924-8579(99)00121-1
Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications.
H. Pinto-Alphandary (2000)
10.1016/S0169-409X(01)00105-3
Solid lipid nanoparticles: production, characterization and applications.
W. Mehnert (2001)
10.1128/AAC.42.2.459
Rationale for and Efficacy of Prolonged-Interval Treatment Using Liposome-Encapsulated Amikacin in Experimental Mycobacterium avium Infection
S. Leitzke (1998)
10.1016/j.ejps.2016.03.009
Improved drug delivery and therapeutic efficacy of PEgylated liposomal doxorubicin by targeting anti-HER2 peptide in murine breast tumor model.
Masoumeh Zahmatkeshan (2016)
10.1016/0005-2736(93)90105-9
Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases.
G. Haran (1993)
10.1016/j.jcis.2010.04.069
Cholesterol induced CTAB micelle-to-vesicle phase transitions.
Mary Cano-Sarabia (2010)
10.1021/JS960403Q
Preparation of liposomes encapsulating water-soluble compounds using supercritical carbon dioxide.
L. Frederiksen (1997)
10.1016/S0927-7765(03)00080-8
Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol
A. Manosroi (2003)
10.5650/JOS.60.209
Preparation of liposomes modified with lipopeptides using a supercritical carbon dioxide reverse-phase evaporation method.
Kenichi Aburai (2011)
10.1021/CG9012312
Kinetically Driven Crystallization of a Pure Polymorphic Phase of Stearic Acid from CO2-Expanded Solutions
S. Sala (2010)
10.1097/MNM.0000000000000505
Preliminary data of the antipancreatic tumor efficacy and toxicity of long-circulating and pH-sensitive liposomes containing cisplatin
F. Carlesso (2016)
10.1208/s12249-016-0489-z
Systematic Development of Transethosomal Gel System of Piroxicam: Formulation Optimization, In Vitro Evaluation, and Ex Vivo Assessment
Varun Garg (2016)
10.1016/J.JCONREL.2005.01.010
Liposome-encapsulated vincristine, vinblastine and vinorelbine: a comparative study of drug loading and retention.
I. V. Zhigaltsev (2005)
10.1016/J.CEJ.2012.01.129
Lipids-based drug carrier systems by dense gas technology: A review
C. C. Beh (2012)
10.1016/J.IJPHARM.2003.08.017
Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages.
S. Vyas (2004)
10.1146/annurev.anchem.1.031207.112747
Liposomes: technologies and analytical applications.
A. Jesorka (2008)
10.1016/J.LFS.2004.05.027
The effect of various liposome formulations on insulin penetration across Caco-2 cell monolayer.
Z. Değim (2004)
10.1002/anie.201310715
Frame-guided assembly of vesicles with programmed geometry and dimensions.
Y. Dong (2014)
10.1016/S0168-3659(03)00358-4
Liposome delivery of ciprofloxacin against intracellular Francisella tularensis infection.
J. P. Wong (2003)
10.1002/ADMA.200300010
Vesicles and Liposomes: A Self-Assembly Principle Beyond Lipids†
M. Antonietti (2003)
10.1016/J.IJPHARM.2005.02.021
Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes.
J. López-Pinto (2005)
10.1016/J.SUPFLU.2011.01.006
Preparation of liposomes using the supercritical anti-solvent (SAS) process and comparison with a conventional method
L. Lesoin (2011)
10.1016/j.addr.2007.09.001
Nanoparticles synthesis using supercritical fluid technology - towards biomedical applications.
K. Byrappa (2008)
10.1038/sj.gt.3302673
Reconstituted influenza virus envelopes as an efficient carrier system for cellular delivery of small-interfering RNAs
J. D. Jonge (2006)
10.1007/s13205-014-0214-0
Nanoemulsion: an advanced mode of drug delivery system
Manjit Jaiswal (2014)
10.1016/j.ejps.2014.05.020
Proniosome-derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection.
Q. Li (2014)
10.1248/BPB.34.945
Niosomes: a controlled and novel drug delivery system.
Rampal Rajera (2011)
10.1021/LA051654U
Preparation of liposomes using an improved supercritical reverse phase evaporation method.
K. Otake (2006)
10.1021/nl4017072
Multifunctional nanovesicle-bioactive conjugates prepared by a one-step scalable method using CO2-expanded solvents.
I. Cabrera (2013)
10.1021/BI00243A021
How membrane chain-melting phase-transition temperature is affected by the lipid chain asymmetry and degree of unsaturation: an effective chain-length model.
G. Cevc (1991)
10.1517/17425240902967607
Pharmacosomes: the lipid-based new drug delivery system
A. Semalty (2009)
10.1089/JOP.2011.0176
Development and evaluation of novel surfactant-based elastic vesicular system for ocular delivery of fluconazole.
I. P. Kaur (2012)
10.1155/2011/326497
Liposomes for Use in Gene Delivery
Daniel A. Balazs (2011)
10.1016/j.jconrel.2012.03.020
Doxil®--the first FDA-approved nano-drug: lessons learned.
Y. Barenholz (2012)
10.1016/j.jcis.2011.04.009
Vesicle formation with amphiphilic chitosan derivatives and a conventional cationic surfactant in mixed systems.
Y. Fan (2011)
10.1016/S0168-3659(02)00017-2
Efficient intracellular drug and gene delivery using folate receptor-targeted pH-sensitive liposomes composed of cationic/anionic lipid combinations.
Guangfeng Shi (2002)
10.1016/j.chemphyslip.2010.12.005
Preparation of submicron liposomes exhibiting efficient entrapment of drugs by freeze-drying water-in-oil emulsions.
Ting Wang (2011)
10.1016/j.cis.2013.11.018
Niosomes from 80s to present: the state of the art.
C. Marianecci (2014)
10.1016/J.IJPHARM.2003.10.006
Deformable liposomes for dermal administration of methotrexate.
M. Trotta (2004)
10.1016/S0083-6729(00)60022-5
Liposome targeting to tumors using vitamin and growth factor receptors.
D. Drummond (2000)
10.1016/0005-2736(86)90231-2
Formation of large unilamellar vesicles using alkyl maltoside detergents
H. Alpes (1986)
10.1016/S0005-2736(01)00369-8
New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes.
G. Cevc (2001)
10.1016/j.addr.2007.11.006
Targeted delivery of nanoparticles for the treatment of lung diseases.
S. Azarmi (2008)
AgullóRueda, Nanotechnology for Microelectronics and Optoelectronics
J. M. Martínez-Duart (2006)
10.1021/ja2086678
Influence of the preparation route on the supramolecular organization of lipids in a vesicular system.
E. Elizondo (2012)
10.1016/J.SUPFLU.2015.02.022
Preparation of liposomes using a modified supercritical process via depressurization of liquid phase
L. Zhao (2015)
10.1016/j.ejpb.2012.02.008
Paclitaxel-loaded ethosomes®: potential treatment of squamous cell carcinoma, a malignant transformation of actinic keratoses.
D. Paolino (2012)
10.4028/www.scientific.net/JNanoR.24.7
Applications of Nanotechnology for Upstream Oil and Gas Industry
S. Ponmani (2013)
10.1016/S0927-7765(02)00048-6
Preparation and physicochemical properties of various soybean lecithin liposomes using supercritical reverse phase evaporation method
Tomohiro Imura (2003)
10.3389/fphar.2015.00219
Lipid-based nano-delivery systems for skin delivery of drugs and bioactives
Susan Hua (2015)
10.1016/J.IJPHARM.2007.03.006
Cationic transfersomes based topical genetic vaccine against hepatitis B.
S. Mahor (2007)
10.1016/j.ijpharm.2014.10.030
High-throughput manufacturing of size-tuned liposomes by a new microfluidics method using enhanced statistical tools for characterization.
E. Kastner (2014)
10.1021/la4003803
Quatsomes: vesicles formed by self-assembly of sterols and quaternary ammonium surfactants.
L. Ferrer-Tasies (2013)
10.2147/IJN.S38378
Nanodrugs: pharmacokinetics and safety
S. Onoue (2014)
10.1016/j.jconrel.2009.10.016
Nanotechnology and the transdermal route: A state of the art review and critical appraisal.
G. Cevc (2010)
10.1016/j.ijpharm.2012.05.011
Niosomes and discomes for ocular delivery of naltrexone hydrochloride: morphological, rheological, spreading properties and photo-protective effects.
H. Abdelkader (2012)
10.1208/s12249-012-9904-2
Evaluation of Meloxicam-Loaded Cationic Transfersomes as Transdermal Drug Delivery Carriers
S. Duangjit (2012)
10.1016/j.jconrel.2014.12.030
Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications.
A. Wicki (2015)
10.1007/s11095-006-0284-8
Nanotechnology: Intelligent Design to Treat Complex Disease
P. Couvreur (2006)
10.1021/acs.langmuir.5b03340
Vesicular Nanostructure Formation by Self-Assembly of Anisotropic Penta-phenol-Substituted Fullerene in Water.
V. Mohanta (2015)
10.1016/J.JCONREL.2005.02.001
Preparation of plasmid DNA-containing liposomes using a high-pressure homogenization--extrusion technique.
E. Pupo (2005)
10.2147/IJN.S26955
A pH-sensitive multifunctional gene carrier assembled via layer-by-layer technique for efficient gene delivery
P. Li (2012)
10.1128/AAC.39.3.725
Therapy of Mycobacterium avium complex infections in beige mice with streptomycin encapsulated in sterically stabilized liposomes.
P. Gangadharam (1995)
10.1556/IMAS.5.2013.3.5
The effects of gamma irradiation on diclofenac sodium, liposome and niosome ingredients for rheumatoid arthritis.
A. Ozer (2013)
10.1016/S1359-6349(04)80607-4
599 Phase I and pharmacokinetic (PK) study of OSI-7904L in combination with Cisplatin (CDDP) in patients with advanced solid tumors
A. Ricart (2004)
10.1021/LA070051A
Microfluidic directed formation of liposomes of controlled size.
A. Jahn (2007)
10.1155/2013/616810
Enhanced Transdermal Delivery of Diclofenac Sodium via Conventional Liposomes, Ethosomes, and Transfersomes
S. Ghanbarzadeh (2013)
10.2217/nnm.13.204
Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine.
H. Xue (2014)
10.1016/j.jconrel.2007.12.011
Efficient drug targeting to rat alveolar macrophages by pulmonary administration of ciprofloxacin incorporated into mannosylated liposomes for treatment of respiratory intracellular parasitic infections.
S. Chono (2008)
10.1158/1535-7163.MCT-07-0615
Antitumor activity of an epithelial cell adhesion molecule–targeted nanovesicular drug delivery system
Sajid. Hussain (2007)
10.1016/S0264-410X(97)00185-0
Transdermal immunisation with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, transfersomes.
A. Paul (1998)
10.2337/DIACARE.28.5.1068
Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.
J. Skyler (2005)
10.1111/j.1348-0421.2004.tb03502.x
Preparation of Virosomes Coated with the Vesicular Stomatitis Virus Glycoprotein as Efficient Gene Transfer Vehicles for Animal Cells
J. Shoji (2004)
10.1016/J.VACCINE.2003.08.024
Efficient delivery of DNA to dendritic cells mediated by influenza virosomes.
M. G. Cusi (2004)
10.1016/S0076-6879(09)65007-2
Microfluidic methods for production of liposomes.
B. Yu (2009)
10.2147/IJN.S39025
Characterization and stability studies of a novel liposomal cyclosporin A prepared using the supercritical fluid method: comparison with the modified conventional Bangham method
P. R. Karn (2013)
10.1039/C4TB01953A
Quatsomes for the treatment of Staphylococcus aureus biofilm.
N. Thomas (2015)
10.1016/J.IJPHARM.2005.02.003
Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages.
S. Vyas (2005)
10.1016/j.ijpharm.2014.10.059
Administration strategies for proteins and peptides.
D. Ibraheem (2014)
10.1371/journal.pone.0145195
Preclinical Evaluation of Liposomal C8 Ceramide as a Potent anti-Hepatocellular Carcinoma Agent
Huiqing Lv (2016)
10.1007/s00216-008-2012-1
An artificial virus-like nano carrier system: enhanced endosomal escape of nanoparticles via synergistic action of pH-sensitive fusogenic peptide derivatives
K. Sasaki (2008)
10.1080/08982100500528842
Reducing Liposome Size with Ultrasound: Bimodal Size Distributions
D. Woodbury (2006)
10.1016/J.JCONREL.2006.04.014
Toxicity of cationic lipids and cationic polymers in gene delivery.
Hongtao Lv (2006)
10.1186/s12885-016-2385-z
HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician’s choice plus trastuzumab in patients with previously treated, anthracycline-naïve, HER2-positive, locally advanced/metastatic breast cancer
K. Miller (2016)
10.1128/AAC.46.12.3776-3781.2002
Pharmacokinetics and Efficacies of Liposomal and Conventional Formulations of Tobramycin after Intratracheal Administration in Rats with Pulmonary Burkholderia cepacia Infection
J. Marier (2002)
10.1002/1098-2299(200007/08)50:3/4<406::AID-DDR23>3.0.CO;2-M
Enhanced delivery of drugs into and across the skin by ethosomal carriers
E. Touitou (2000)
10.1186/s13550-015-0096-0
Whole-body organ-level and kidney micro-dosimetric evaluations of 64Cu-loaded HER2/ErbB2-targeted liposomal doxorubicin (64Cu-MM-302) in rodents and primates
D. Gaddy (2015)
10.4103/0975-7406.103274
Formulation and optimization of nano-sized ethosomes for enhanced transdermal delivery of cromolyn sodium
R. Rakesh (2012)
10.2217/NNM.12.110
Nanostructuring molecular materials as particles and vesicles for drug delivery, using compressed and supercritical fluids.
E. Elizondo (2012)
10.1021/LA020589A
Control of physicochemical properties of liposomes using a supercritical reverse phase evaporation method
Tomohiro Imura (2003)
10.15171/apb.2015.074
Nanoethosomes for Dermal Delivery of Lidocaine.
Soraya Babaie (2015)
10.1021/LA0348113
Self-organization and Microstructures of Sodium 11-Acrylamidoundecanoate in Water
Sumita Roy and (2003)
10.1016/J.IJPHARM.2006.02.051
Application of aerosol solvent extraction system (ASES) process for preparation of liposomes in a dry and reconstitutable form.
Sarinnate Kunastitchai (2006)
10.5958/2321-5844.2015.00003.5
Ethosomes: A Novel Approach for Transdermal and Topical Drug Delivery
Roohi Kesharwani (2015)
10.2217/17435889.1.3.297
Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential
M. Immordino (2006)
10.3109/02652048.2011.629742
Preparation of coenzyme Q10 liposomes using supercritical anti-solvent technique
Fei Xia (2012)
10.1016/j.immuni.2011.01.015
Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges.
M. Bomsel (2011)
10.1016/J.SUPFLU.2011.04.018
Development of a continuous dense gas process for the production of liposomes
L. Lesoin (2011)
10.2147/IJN.S65408
Experimental design and optimization of raloxifene hydrochloride loaded nanotransfersomes for transdermal application
S. Mahmood (2014)
10.1208/s12249-008-9105-1
Niosome-Encapsulated Gentamicin for Ophthalmic Controlled Delivery
G. Abdelbary (2008)
10.1016/j.biomaterials.2015.11.017
The influence of the polar head-group of synthetic cationic lipids on the transfection efficiency mediated by niosomes in rat retina and brain.
E. Ojeda (2016)
10.1016/S0005-2736(02)00401-7
Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements.
G. Cevc (2002)
Transfersomes: self-optimizing carriers for bioactives.
K. Rai (2008)
10.1155/2011/418316
Characterization and In Vitro Skin Permeation of Meloxicam-Loaded Liposomes versus Transfersomes
S. Duangjit (2011)
10.1016/S0022-2836(65)80093-6
Diffusion of univalent ions across the lamellae of swollen phospholipids.
A. Bangham (1965)
10.1016/S0264-410X(02)00567-4
Novel approaches in the development of immunopotentiating reconstituted influenza virosomes as efficient antigen carrier systems.
R. Glueck (2003)
10.1016/S0168-3659(99)00222-9
Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties.
E. Touitou (2000)
10.3109/02652048.2013.788088
Niosomes encapsulating paclitaxel for oral bioavailability enhancement: preparation, characterization, pharmacokinetics and biodistribution
Zerrin Sezgin-Bayindir (2013)
10.1016/j.colsurfb.2014.01.029
Physicochemical characterization and cytotoxic studies of nonionic surfactant vesicles using sucrose esters as oral delivery systems.
K. Valdés (2014)
10.1158/1538-7445.AM2016-CT154
Abstract CT154: Phase I dose-escalating PoC study to evaluate the safety and tolerability of LiPlaCis (liposomal cisplatin formulation) in patients with advanced or refractory tumors
U. Lassen (2016)
10.1016/j.jconrel.2009.03.019
Aerosolized liposomes with dipalmitoyl phosphatidylcholine enhance pulmonary insulin delivery.
S. Chono (2009)
10.1016/j.chemphyslip.2013.10.011
Novel methods for liposome preparation.
Yogita P Patil (2014)
10.1021/nn900002m
Impact of nanotechnology on drug delivery.
O. Farokhzad (2009)
10.1038/bjc.1995.430
Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models.
M. Webb (1995)
10.1158/1538-7445.AM2014-CT216
Abstract CT216: Phase I dose escalating study of 2B3-101, glutathione PEGylated liposomal doxorubicin, in patients with solid tumors and brain metastases or recurrent malignant glioma
P. J. Gaillard (2014)
10.1016/j.msec.2014.10.070
Uptake and transport of insulin across intestinal membrane model using trimethyl chitosan coated insulin niosomes.
Saeid Moghassemi (2015)
10.1021/LA010122K
Development of a New Preparation Method of Liposomes Using Supercritical Carbon Dioxide
K. Otake (2001)
10.1371/journal.pone.0045374
Peptide Nanovesicles Formed by the Self-Assembly of Branched Amphiphilic Peptides
Sushanth Gudlur (2012)
10.1038/sj.clpt.6100400
Nanoparticles in Medicine: Therapeutic Applications and Developments
L. Zhang (2008)
Liposomes : a practical approach
R. New (1990)
10.1016/0009-3084(67)90030-8
Osmotic properties and water permeability of phospholipid liquid crystals
A. D. Bangham (1967)
10.4103/2231-4040.97286
Effect of permeation enhancers on the penetration mechanism of transfersomal gel of ketoconazole
Reshmy Rajan (2012)
10.1111/j.1467-2494.1979.tb00224.x
Dispersions of lamellar phases of non‐ionic lipids in cosmetic products
R. Handjani-Vila (1979)
10.1093/JAC/38.5.819
Liposomal amikacin: improved treatment of Mycobacterium avium complex infection in the beige mouse model.
E. Petersen (1996)
10.1039/C1SM05961K
Self-assembled liposomes from amphiphilic electrospun nanofibers
Deng-Guang Yu (2011)
10.1016/0005-2736(85)90521-8
Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size distribution, trapped volume and ability to maintain a membrane potential.
M. Hope (1985)
10.1038/nrd4363
Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies
S. Mitragotri (2014)
10.1016/0378-5173(93)90422-C
Preparation of liposomes using a Mini-Lab 8.30 H high-pressure homogenizer
D. Bachmann (1993)
10.4103/2230-973X.138342
Nanovesicles for transdermal delivery of felodipine: Development, characterization, and pharmacokinetics
M. Yusuf (2014)
10.1021/la7032109
Preparation of uniform rich cholesterol unilamellar nanovesicles using CO2-expanded solvents.
M. Cano-Sarabia (2008)
10.1002/adhm.201500746
α-Galactosidase-A Loaded-Nanoliposomes with Enhanced Enzymatic Activity and Intracellular Penetration.
I. Cabrera (2016)
10.1016/j.colsurfb.2010.08.004
Novel pH-sensitive non-ionic surfactant vesicles: comparison between Tween 21 and Tween 20.
L. Di Marzio (2011)
10.1208/s12249-008-9097-x
Conventional and Dense Gas Techniques for the Production of Liposomes: A Review
Louise A. Meure (2008)
10.1016/S0076-6879(03)67003-5
Preparation and quantitation of small unilamellar liposomes and large unilamellar reverse-phase evaporation liposomes.
N. Düzgüneş (2003)
New, in Liposomes: a practical approach, ed
R C.R. (1990)
10.3109/21691401.2013.794351
Oleic acid vesicles: a new approach for topical delivery of antifungal agent
S. Verma (2014)
10.1211/jpp.58.4.0005
Ethinylestradiol‐loaded ultraflexible liposomes: pharmacokinetics and pharmacodynamics
M. Garg (2006)
10.1089/10430349950016762
RNA melanoma vaccine: induction of antitumor immunity by human glycoprotein 100 mRNA immunization.
W. Zhou (1999)
10.1016/j.jconrel.2016.03.012
Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation.
Fatemeh Ravar (2016)
10.2174/156720107780362339
Recent advances in protein and peptide drug delivery systems.
Dhirendra Kumar Malik (2007)
10.1016/j.biopha.2015.05.002
Improved anti-melanoma effect of a transdermal mitoxantrone ethosome gel.
X. Yu (2015)
10.1021/mp300202c
Oral delivery of doxorubicin using novel polyelectrolyte-stabilized liposomes (layersomes).
S. Jain (2012)
10.1038/nrd2591
Strategies in the design of nanoparticles for therapeutic applications
Robby A. Petros (2010)
10.1016/S0168-3659(96)01566-0
Transfersomes-mediated transepidermal delivery improves the regio-specificity and biological activity of corticosteroids in vivo
G. Cevc (1997)
10.1166/JBN.2010.1101
Tissue distribution, pharmacokinetics and stability studies of zidovudine delivered by niosomes and proniosomes.
K. Ruckmani (2010)
10.3109/10731199.2011.585618
Preparation and Influencing Factors of Sirolimus Liposome by Supercritical Fluid
W. Zhang (2012)
10.1016/0005-2736(91)90295-J
Small-volume extrusion apparatus for preparation of large, unilamellar vesicles.
R. Macdonald (1991)
10.1016/j.ddtec.2009.01.002
Intracellular delivery of protein and peptide therapeutics.
V. Torchilin (2008)
10.1097/CAD.0b013e328346c7d6
Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in-vitro release, and cytotoxicity analysis
I. A. Alvi (2011)
10.1021/IE00071A021
Rapid expansion of supercritical fluid solutions: solute formation of powders, thin films, and fibers
D. Matson (1987)
10.1016/S0140-6736(75)92130-3
FORMATION OF VIROSOMES FROM INFLUENZA SUBUNITS AND LIPOSOMES
J. Almeida (1975)
10.3389/fphar.2015.00001
Potential role of glutathione in evolution of thiol-based redox signaling sites in proteins
K. Mohanasundaram (2015)
10.3109/1061186X.2015.1070855
Nanosized ethosomes-based hydrogel formulations of methoxsalen for enhanced topical delivery against vitiligo: formulation optimization, in vitro evaluation and preclinical assessment
B. Garg (2016)
10.1166/JBN.2010.1121
Development and performance evaluation of amphotericin B transfersomes against resistant and sensitive clinical isolates of visceral leishmaniasis.
D. Singodia (2010)
10.1016/J.EJPS.2003.09.008
Delivery of liposomes in dry powder form: aerodynamic dispersion properties.
T. Desai (2003)
10.2147/DDDT.S81236
Preparation and clinical evaluation of nano-transferosomes for treatment of erectile dysfunction
M. F. Ali (2015)
10.1016/S0169-409X(00)00069-7
Virosomes: evolution of the liposome as a targeted drug delivery system.
Y. Kaneda (2000)
10.1155/2014/574673
Lipid Based Vesicular Drug Delivery Systems
S. Jain (2014)
10.4314/TJPR.V6I1.14641
Modified Transdermal Technologies: Breaking the Barriers of Drug Permeation via the Skin
R. Kumar (2007)
10.3109/08982104.2014.881850
Preparation, characterization and evaluation of novel elastic nano-sized niosomes (ethoniosomes) for ocular delivery of prednisolone
Passent M E Gaafar (2014)
10.1021/la901366g
Facile preparation of novel peptosomes through complex self-assembly of hyperbranched polyester and polypeptide.
B. Guo (2009)



This paper is referenced by
10.1039/c8nr07110a
Insights into the structure and nanomechanics of a quatsome membrane by force spectroscopy measurements and molecular simulations.
Berta Gumí-Audenis (2018)
Formulation and Characterization of Lipogels as a Tunable Delivery Scaffold
Celia C Homyak (2018)
Development of Ligand-Directed Drug-Loaded Liposomes to Target Heterogeneous Tumour Cell Populations in Metastatic Breast Cancer
L. Belfiore (2019)
10.1002/adfm.201904268
Toxico‐Metabolomics of Engineered Nanomaterials: Progress and Challenges
Farooq Ahmad (2019)
10.1016/j.jconrel.2020.09.051
Designing intelligent nano-bomb with on-demand site-specific drug burst release to synergize with high-intensity focused ultrasound cancer ablation.
Xiaoxuan Mai (2020)
Single-molecule studies of the replisome: Visualisation of protein dynamics in multi-protein complexes
L. Spenkelink (2018)
10.1371/journal.pone.0187962
Understanding the formation mechanism of lipid nanoparticles in microfluidic devices with chaotic micromixers
Masatoshi Maeki (2017)
10.2174/1573395514666180605092054
Mucosal Vaccine Approaches for Prevention of HIV and SIV Transmission.
P. Kozlowski (2019)
10.1016/j.jddst.2020.102016
Advances in delivery systems for the therapeutic application of LL37
Xiaoxuan Lin (2020)
10.1002/MACP.201800071
In Situ Template Polymerization to Prepare Liposome‐Coated PDMAEMA Nanogels with Controlled Size, High Stability, Low Cytotoxicity, and Responsive Drug Release for Intracellular DOX Release
X. Zhao (2018)
10.1016/j.addr.2020.02.005
Nanotechnology approaches in the current therapy of skin cancer.
L. N. Borgheti-Cardoso (2020)
10.1134/S1068162018060092
High Density Lipoproteins Phosphatidylcholine as a Regulator of Reverse Cholesterol Transport
T. I. Torkhovskaya (2018)
10.1093/femsre/fuz021
Impact of nanosystems in Staphylococcus aureus biofilms treatment.
R. M. Pinto (2019)
Treball Final de Màster
Noelia González Arias (2018)
New fluorescent nanovesicles, by self-assembly of organic fluorophores, sterols and surfactants, as probes for bioimaging
Antonio Ardizzone (2017)
10.3389/fonc.2019.00602
Folic Acid Receptor-Mediated Targeting Enhances the Cytotoxicity, Efficacy, and Selectivity of Withania somnifera Leaf Extract: In vitro and in vivo Evidence
Yue Yu (2019)
10.3390/pharmaceutics12070641
N-Alkylisatin-Loaded Liposomes Target the Urokinase Plasminogen Activator System in Breast Cancer
L. Belfiore (2020)
10.1021/acs.langmuir.7b03539
Highly Fluorescent Silicon Nanocrystals Stabilized in Water Using Quatsomes.
Dorothy Silbaugh (2017)
10.1002/adma.201806774
Modular Metal-Organic Polyhedra Superassembly: From Molecular-Level Design to Targeted Drug Delivery.
Wei Zhu (2019)
10.1016/j.actbio.2017.08.010
Lipogels responsive to near-infrared light for the triggered release of therapeutic agents.
F. Martín-Saavedra (2017)
10.1088/2050-6120/aa8f57
NIR-fluorescent dye doped silica nanoparticles for in vivo imaging, sensing and theranostic.
E. Rampazzo (2018)
10.1039/C7NJ00641A
Probing the formation of supramolecular assemblies of amphiphilic N-methyl glycine and N,N dimethyl β-alanine derivatives
Nicole M. Cutrone (2017)
10.1128/JVI.00443-17
Covalent Linkage of HIV-1 Trimers to Synthetic Liposomes Elicits Improved B Cell and Antibody Responses
Shridhar Bale (2017)
10.3390/biom10020169
Cymbopogon Citratus Functionalized Green Synthesis of CuO-Nanoparticles: Novel Prospects as Antibacterial and Antibiofilm Agents
Tijo Cherian (2020)
10.3390/ph12040146
Anticancer Ruthenium(III) Complexes and Ru(III)-Containing Nanoformulations: An Update on the Mechanism of Action and Biological Activity
C. Riccardi (2019)
10.1007/978-3-030-01775-0_9
Oral Nanotherapeutics for Cancer with Innovations in Lipid and Polymeric Nanoformulations
Alexander J. Donovan (2019)
10.1039/d0nr01702g
Cyclodextrin-based superparamagnetic host vesicles as ultrasensitive nanobiocarriers for electrosensing.
J. Muñoz (2020)
10.1038/s41401-020-0417-3
Nanoengineered targeting strategy for cancer immunotherapy
Wei-min Yin (2020)
10.1002/anie.202009572
Cationic Lipid-based Intracellular Delivery of Bacterial Effectors for Rewiring Malignant Cell Signaling.
S. Yang (2020)
10.2217/nnm-2020-0097
Biomimetic nanovesicle design for cardiac tissue repair.
Sruti Bheri (2020)
10.1155/2016/5482087
Mucosal Vaccine Development Based on Liposome Technology
V. Bernasconi (2016)
10.1039/c9cc05691b
Incorporation of 7-dehydrocholesterol into liposomes as a simple, universal and efficient way to enhance anticancer activity by combining PDT and photoactivated chemotherapy.
Youchao Wang (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar